Ankyra Therapeutics Announces $45 Million Series B Financing and Appoints Howard L. Kaufman M.D. as Chief Medical Officer

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3ojls4e
via IFTTT